TrialInvestigational new drugs2019

Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer.

G Weldon Gilcrease et al.PubMed ↗Publisher ↗

No numbers read from the abstract.